Advanced Therapies – Opportunities and Challenges – Speakers 2017-11-21T15:55:13+00:00

Organised in partnership with:

Advanced Therapies – Opportunities and Challenges

14th November, London

Speakers

Richard Barker

Founding Director,
Centre for the Advancement of Sustainable Medical Innovation (CASMI)

Steve Bates

Chief Executive Officer,
BioIndustry Association (BIA)

Eduardo Bravo

Chief Executive Officer,
TiGenix
& EBE President

Ian Campbell

Director for Health and Life Sciences,
Innovate UK

Barbara Freischem

Executive Director,
European Biopharmaceutical Enterprises (EBE)

Peter Goodfellow

Scientific Advisor,
Abingworth

Karen Hodgkin

Chief Operating Officer,
Cell Medica

Seigo Izumo

Senior Vice President for Regenerative Medicine,
Takeda Pharmaceuticals

Adrien Lemoine

VP Business Development & Operations,
Orchard Therapeutics

James McBlane

CAT Member,
Preclinical Assessor,
UK Medicines and Healthcare Products Regulatory Agency (MHRA)

Deborah Morrison

Senior Scientific Adviser,
National Institute for Health and Care Excellence (NICE)

Lord James O’Shaughnessy

Parliamentary Under Secretary of State for Health (Lords),
UK Government

Magda Papadaki

Head of Product and Process Innovation,
Association of the British Pharmaceutical Industry (ABPI)

Michaël Hocquemiller

Scientific Director,
Lysogene

Gabriele Proetzel,

Director, Regenerative Medicine,
Takeda

Qasim Rafiq

Senior Lecturer,
Bioprocessing of Regenerative, Cellular and Gene Therapies,
UCL

Christian K Schneider

Director,
National Institute for Biological Standards and Control
(NIBSC)

Duane Schulthess

Managing Director,
Vital Transformation

Michael Stein

Chief Executive Officer and Chairman,
Oxstem

Keith Thompson

Chief Executive Officer,
Cell and Gene Therapy Catapult

Supported by: